Squarepoint Ops LLC Krystal Biotech, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 15,706 shares of KRYS stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,706

Previous 2,408 552.24%

Holding current value

$2.68 Million

Previous $442,000 546.15%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$174.7 - $213.66 $2.32 Million - $2.84 Million	13,298 Added 552.24%	15,706 $2.86 Million
Q2 2024 Aug 14, 2024	BUY	$153.12 - $183.64 $368,712 - $442,205	2,408 New	2,408 $442,000
Q4 2023 Feb 14, 2024	BUY	$96.0 - $128.29 $356,064 - $475,827	3,709 New	3,709 $460,000
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $539,552 - $685,568	8,320 New	8,320 $580,000
Q1 2022 May 16, 2022	SELL	$51.99 - $72.11 $1.13 Million - $1.57 Million	-21,794 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $354,667 - $786,130	8,909 Added 69.14%	21,794 $1.52 Million
Q3 2021 Nov 15, 2021	BUY	$52.01 - $71.77 $436,051 - $601,719	8,384 Added 186.27%	12,885 $673,000
Q2 2021 Aug 16, 2021	BUY	$62.14 - $81.82 $279,692 - $368,271	4,501 New	4,501 $306,000
Q3 2020 Nov 16, 2020	SELL	$37.76 - $48.49 $217,422 - $279,205	-5,758 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$37.03 - $60.0 $213,218 - $345,480	5,758 New	5,758 $238,000
Q1 2020 May 15, 2020	SELL	$35.02 - $65.64 $411,905 - $772,057	-11,762 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$33.17 - $65.23 $668,275 - $1.31 Million	-20,147 Reduced 63.14%	11,762 $651,000
Q3 2019 Nov 14, 2019	SELL	$34.72 - $51.3 $261,059 - $385,724	-7,519 Reduced 19.07%	31,909 $1.11 Million
Q2 2019 Aug 14, 2019	BUY	$27.2 - $41.2 $891,534 - $1.35 Million	32,777 Added 492.81%	39,428 $1.59 Million
Q1 2019 May 15, 2019	BUY	$19.86 - $32.9 $132,088 - $218,817	6,651 New	6,651 $219,000
Q1 2018 May 15, 2018	SELL	$8.61 - $11.74 $92,988 - $126,792	-10,800 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.19 - $11.19 $88,452 - $120,852	10,800	10,800 $114,000

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.38B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Krystal Biotech, Inc. Transaction History